article · Egyptian Journal of Ear Nose Throat and Allied Sciences
Objectives: To evaluate the role of partial middle turbinectomy (PMT) in patients with allergic fungal sinusitis (AFS) managed by endoscopic sinus surgery (ESS) in the prevention of recurrence and adequate management of residual disease.Patients and Methods: This prospective study, conducted on 60 patients, suffering from AFS diagnosed clinically and radiologically after presenting to the Otolaryngology clinic at faculty of medicine Cairo University and Misr University for Science and Technology during the period of March 2021 to August 2022. Patients were randomly divided into 2 equal groups. All Patients underwent ESS. The middle turbinate was preserved in Group A patients while PMT was performed in group B patients. Both the groups were compared postoperatively in the outpatient clinic in a period of up to 9 months in the outpatient clinic to detect recurrence of allergic fungal sinusitis, patency of sinuses was assessed endoscopically.Results: In the current study we found that recurrence was less frequent in PMT group at 6 months follow up 0.0% (n=0) (Group B turbinectomy Group) compared to recurrence 20.0% (n=6) in (Group A preserved Group) the differences started to be statistically significant after the 6 months assessment point. And was still significantly lower at 13.3% (n=4) compared to 36.7% (n=11) after 9 months. Also, there were no significant incidences of bleeding or orbital injury in either group.Conclusion: This study demonstrated that PMT decreased the chances of recurrence of disease.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejentas.2023.162584.1558
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.